QuidelOrtho Receives FDA 510(k) Clearance for its VITROS Syphilis Assay SAN DIEGO, August 29, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") has received U.S. Food ...
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu ...
DiaSorin is a niche player in the fragmented in vitro diagnostic, or IVD, market with specialization in infectious diseases. Its systems can perform tests for a wide range of diseases including ...
The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms ...
Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2024-2032. Read the ...